Tag:
PentaStaph
Latest Headlines
Latest Headlines
Nabi sells staph vax program to GSK for $46M
Nabi Biopharmaceuticals has struck a deal to sell off another big piece of itself. GlaxoSmithKline agreed to pay $46 million--$20 million upfront--for its PentaStaph program, a vaccine in development
